Stay updated on Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record for SCM-AGH in people with moderate to severe atopic dermatitis is now displayed, including its Phase I/II design, participant criteria, treatment arms, and outcome measures. The record shows the study is completed and is no longer recruiting participants.
    Difference
    52%
    Check dated 2026-11-07T13:30:27.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T14:18:25.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner was added above the error page announcing NIH website transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T13:48:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:55:10.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the study record page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:39:09.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal HTML snippet and a Home button, indicating an access issue rather than a change to the study information.
    Difference
    20%
    Check dated 2026-09-19T19:13:32.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.